• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday

    7/11/24 10:10:16 AM ET
    $APGE
    $ASTH
    $CHWY
    $EMBC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $APGE alert in real time by email

    U.S. stocks were mostly higher, with the Dow Jones index gaining around 100 points on Thursday.

    Shares of Methode Electronics, Inc. (NYSE:MEI) rose sharply during Thursday's session after the company reported better-than-expected fourth-quarter sales results.

    Methode Electronics reported a fourth-quarter fiscal 2024 net sales decline of 7.9% year-on-year to $277.30 million, beating the analyst consensus estimate of $264.04 million. Adjusted EPS loss of 23 cents missed the analyst consensus loss estimate of 20 cents, according to data from Benzinga Pro.

    Methode Electronics shares surged 29.4% to $12.22 on Thursday.

    Here are some other big stocks recording gains in today’s session.

    • QuantumScape Corporation (NYSE:QS) shares jumped 25% to $6.76 after the company announced it entered into an agreement with PowerCo to industrialize solid-state batteries.
    • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) gained 18.2% to $8.63.
    • SoundHound AI, Inc. (NASDAQ:SOUN) shares gained 16.7% to $5.92. SoundHound AI recently announced that its ChatGPT-integrated voice assistant is now live and in production in Peugeot, Opel and Vauxhall vehicle brands in Europe.
    • Pacific Biosciences of California, Inc. (NASDAQ:PACB) rose 14% to $1.48.
    • Embecta Corp. (NASDAQ:EMBC) gained 11.7% to $13.40.
    • Astrana Health, Inc. (NASDAQ:ASTH) jumped 11.2% to $42.47. Truist Securities analyst Jailendra Singh upgraded Astrana Health from Hold to Buy and raised the price target from $44 to $50.
    • Ribbon Communications Inc. (NASDAQ:RBBN) gained 10.8% to $3.60 after Rosenblatt initiated coverage on the stock with a Buy rating and announced a $5 price target.
    • Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) rose 9.5% to $8.52.
    • Apogee Therapeutics, Inc. (NASDAQ:APGE) climbed 9.2% to $46.08.
    • Joby Aviation, Inc. (NASDAQ:JOBY) gained 8.2% to $5.61. Joby Aviation said it has flown a first-of-its-kind hydrogen-electric air taxi demonstrator 523 miles, with water as the only by-product.
    • Lantheus Holdings, Inc. (NASDAQ:LNTH) surged 8.2% to $114.89. Leerink Partners maintained Lantheus with an Outperform and raised the price target from $106 to $127.
    • MicroStrategy Incorporated (NASDAQ:MSTR) shares climbed 8% to $1,410.01 after the company announced a 10-for-1 stock split.
    • Unity Software Inc. (NYSE:U) gained 7.4% to $16.51. Unity is expected to release second quarter financial results after the closing bell on Aug. 8.
    • Q2 Holdings, Inc. (NASDAQ:QTWO) rose 6.8% to $64.81.
    • Enphase Energy, Inc. (NASDAQ:ENPH) climbed 6.8% to $113.99 after the company announced residential and commercial products that can help solar projects qualify for the “Domestic Content Bonus Credit.”
    • Pool Corporation (NASDAQ:POOL) rose 6.6% to $318.49.
    • Installed Building Products, Inc. (NYSE:IBP) gained 6.4% to $223.75.
    • Yum China Holdings, Inc. (NYSE:YUMC) rose 5.5% to $32.17.
    • Chewy, Inc. (NYSE:CHWY) gained 4.6% to $26.57.

    Now Read This:

    • How To Earn $500 A Month From JPMorgan Chase Stock Ahead Of Q2 Earnings Report
    Get the next $APGE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APGE
    $ASTH
    $CHWY
    $EMBC

    CompanyDatePrice TargetRatingAnalyst
    Installed Building Products Inc.
    $IBP
    2/11/2026Buy → Hold
    The Benchmark Company
    Unity Software Inc.
    $U
    2/10/2026$38.00Perform → Outperform
    Oppenheimer
    Terns Pharmaceuticals Inc.
    $TERN
    2/9/2026$58.00Outperform
    Leerink Partners
    Ribbon Communications Inc.
    $RBBN
    2/6/2026$2.90Buy → Neutral
    B. Riley Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    Enphase Energy Inc.
    $ENPH
    2/4/2026$35.00 → $40.00Hold
    TD Cowen
    More analyst ratings

    $APGE
    $ASTH
    $CHWY
    $EMBC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Terns Pharmaceuticals Inc.

    SCHEDULE 13G/A - Terns Pharmaceuticals, Inc. (0001831363) (Subject)

    2/12/26 5:01:46 PM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pacific Biosciences of California Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Filer)

    2/12/26 4:10:44 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Lantheus Holdings Inc.

    SCHEDULE 13G/A - Lantheus Holdings, Inc. (0001521036) (Subject)

    2/12/26 12:50:04 PM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $APGE
    $ASTH
    $CHWY
    $EMBC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 16, 2024 - FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

    For Immediate Release: February 16, 2024 Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery (unresectable) or has spread to other parts of the body (metastatic) that previously has been treated with other therapies (a PD-1 blocking antibody, and if B

    2/16/24 3:48:47 PM ET
    $IOVA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $APGE
    $ASTH
    $CHWY
    $EMBC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    Director Thompson Michael N. Jr. bought $14,564 worth of shares (1,100 units at $13.24) (SEC Form 4)

    4 - Joby Aviation, Inc. (0001819848) (Issuer)

    1/2/26 4:43:46 PM ET
    $JOBY
    Aerospace
    Industrials

    President & CEO Kothandaraman Badrinarayanan bought $153,438 worth of shares (5,000 units at $30.69) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    11/10/25 4:42:21 PM ET
    $ENPH
    Semiconductors
    Technology

    $APGE
    $ASTH
    $CHWY
    $EMBC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Q2 Releases 2026 State of Commercial Banking Report

    New findings show rising client expectations and increasing pricing pressure as banks and credit unions navigate margin compression, digital modernization, and heightened competition Q2 Holdings, Inc. (NYSE:QTWO), a leading provider of digital transformation solutions for financial services, today announces its State of Commercial Banking January 2026 report. Key findings from the annual report reveal major trends in the commercial banking industry, as well as the challenges and opportunities banks and credit unions will face in the coming year. As businesses navigate continued economic uncertainty, they increasingly expect their financial institutions to provide faster payments, real-t

    2/12/26 4:30:00 PM ET
    $QTWO
    Computer Software: Prepackaged Software
    Technology

    PacBio Announces Fourth Quarter and Full Year 2025 Financial Results

    MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results:  Q4 2025Q4 2024FY 2025FY 2024Revenue (in millions)$44.6$39.2$160.0$154.0Consumable revenue (in millions)$21.6$18.8$82.0$70.3Instrument revenue (in millions)$17.3$15.3$53.8$65.8Service and other revenue (in millions)$5.7$5.1$24.2$17.9RevioTM system placements21236197VegaTM system placements4271407Annualized Revio pull-through per system~$242,000~$240,000~$233,000~$252,000Ending cash, cash equivalents, and investments(in millions)$279.5$389.9   Gross margin, operating expenses, net inco

    2/12/26 4:05:00 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Installed Building Products to Report Fourth Quarter and Fiscal Year 2025 Financial Results

    Installed Building Products, Inc. (the "Company") (NYSE:IBP), an industry-leading installer of insulation and complementary building products, announced today that the Company will release its fourth quarter and fiscal 2025 financial results on February 26, 2026. A webcast and conference call will be held that same day at 10:00 a.m. (Eastern Time) to review the Company's results. Webcast: The conference call will be available on the investor relations section of the Company's website at www.installedbuildingproducts.com. To listen to a live webcast, go to the site at least 15 minutes prior to the scheduled start time to register, download and install any necessary audio software. To P

    2/12/26 8:00:00 AM ET
    $IBP
    Homebuilding
    Consumer Discretionary

    $APGE
    $ASTH
    $CHWY
    $EMBC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Installed Building Products downgraded by The Benchmark Company

    The Benchmark Company downgraded Installed Building Products from Buy to Hold

    2/11/26 6:57:04 AM ET
    $IBP
    Homebuilding
    Consumer Discretionary

    Unity Software upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Unity Software from Perform to Outperform and set a new price target of $38.00

    2/10/26 7:17:53 AM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    Leerink Partners initiated coverage on Terns Pharmaceuticals with a new price target

    Leerink Partners initiated coverage of Terns Pharmaceuticals with a rating of Outperform and set a new price target of $58.00

    2/9/26 6:54:14 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APGE
    $ASTH
    $CHWY
    $EMBC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mora Richard sold $57,254 worth of shares (1,100 units at $52.05), decreasing direct ownership by 11% to 9,370 units (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/12/26 7:15:04 PM ET
    $ENPH
    Semiconductors
    Technology

    Chief Commercial Officer Kirby Daniel Gordon converted options into 39,996 shares and covered exercise/tax liability with 16,450 shares, increasing direct ownership by 78% to 53,546 units (SEC Form 4)

    4 - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Issuer)

    2/12/26 5:00:14 PM ET
    $IOVA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Financial Officer Ding Adrian converted options into 3,733 shares and covered exercise/tax liability with 1,681 shares, increasing direct ownership by 4% to 52,398 units (SEC Form 4)

    4 - Yum China Holdings, Inc. (0001673358) (Issuer)

    2/12/26 9:56:18 AM ET
    $YUMC
    Restaurants
    Consumer Discretionary

    $APGE
    $ASTH
    $CHWY
    $EMBC
    Leadership Updates

    Live Leadership Updates

    View All

    Unity Appoints Bernard Kim to its Board of Directors and Announces Board Transitions

    Unity (NYSE:U), the world's leading game engine, today announced the appointment of gaming and technology veteran Bernard Kim as an independent director to its Board of Directors, effective May 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210709281/en/Bernard Kim "Bernard brings deep experience building and scaling global, public companies at the intersection of games and technology," said Jim Whitehurst, Chairman of Unity's Board of Directors. "His leadership across mobile gaming, advertising technology, and consumer platforms will be a valuable addition to the Unity Board." "Unity plays a foundational role in h

    2/10/26 4:15:00 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    QuantumScape Welcomes Tech Industry Veteran Geoff Ribar to Board of Directors

    QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced the appointment of Geoff Ribar to its board of directors. Ribar brings deep expertise and extensive leadership experience in the technology industry, with decades serving as CFO for companies across the sector. Ribar was Chief Financial Officer at Cadence Design Systems from 2010 to 2017 and previously served as CFO at Telegent Systems, Matrix Semiconductor and NVIDIA Corporation, among others. He was formerly Vice President and corporate controller at Advanced Micro Devices (AMD). He also serves on the board of directors at Acacia Research Corporation, Ev

    1/30/26 6:55:00 AM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    Pool Corporation Announces the Retirement of Kenneth G. St. Romain and the Appointment of John B. Watwood

    COVINGTON, La., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq/GSM: POOL) announced today that Kenneth "Kenny" G. St. Romain, Senior Vice President, will retire from his position in 2026, and that John B. Watwood has joined the company as Executive Vice President. Mr. Watwood, reporting to Peter D. Arvan, President and CEO, will lead Pool Corporation's swimming pool operations in North America, as well as oversee digital and technology initiatives. Mr. St. Romain will continue in his role until later this year to assist with the transition. "For more than 40 years, Kenny has been a steady and trusted leader, playing a pivotal role in shaping POOLCORP as the leading distributor

    1/12/26 4:05:00 PM ET
    $POOL
    Industrial Specialties
    Consumer Discretionary

    $APGE
    $ASTH
    $CHWY
    $EMBC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Pacific Biosciences of California Inc.

    SC 13G - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)

    11/26/24 8:27:01 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Terns Pharmaceuticals Inc.

    SC 13G/A - Terns Pharmaceuticals, Inc. (0001831363) (Subject)

    11/15/24 10:35:07 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Lantheus Holdings Inc.

    SC 13G - Lantheus Holdings, Inc. (0001521036) (Subject)

    11/14/24 8:21:14 PM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $APGE
    $ASTH
    $CHWY
    $EMBC
    Financials

    Live finance-specific insights

    View All

    PacBio Announces Fourth Quarter and Full Year 2025 Financial Results

    MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results:  Q4 2025Q4 2024FY 2025FY 2024Revenue (in millions)$44.6$39.2$160.0$154.0Consumable revenue (in millions)$21.6$18.8$82.0$70.3Instrument revenue (in millions)$17.3$15.3$53.8$65.8Service and other revenue (in millions)$5.7$5.1$24.2$17.9RevioTM system placements21236197VegaTM system placements4271407Annualized Revio pull-through per system~$242,000~$240,000~$233,000~$252,000Ending cash, cash equivalents, and investments(in millions)$279.5$389.9   Gross margin, operating expenses, net inco

    2/12/26 4:05:00 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Installed Building Products to Report Fourth Quarter and Fiscal Year 2025 Financial Results

    Installed Building Products, Inc. (the "Company") (NYSE:IBP), an industry-leading installer of insulation and complementary building products, announced today that the Company will release its fourth quarter and fiscal 2025 financial results on February 26, 2026. A webcast and conference call will be held that same day at 10:00 a.m. (Eastern Time) to review the Company's results. Webcast: The conference call will be available on the investor relations section of the Company's website at www.installedbuildingproducts.com. To listen to a live webcast, go to the site at least 15 minutes prior to the scheduled start time to register, download and install any necessary audio software. To P

    2/12/26 8:00:00 AM ET
    $IBP
    Homebuilding
    Consumer Discretionary

    Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

    BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the "Company") (NASDAQ:LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 26, 2026, to discuss its financial and operating results for the fourth quarter and full year of 2025. To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time. A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least

    2/12/26 8:00:00 AM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care